|
产品编号
|
中文名称
|
英文名称
|
|
SRNC-20/174
|
First WHO International Standard for anti-human papillomavirus type 11 serum
|
First WHO International Standard for anti-human papillomavirus type 11 serum
|
|
SRNC-20/176
|
First WHO International Standard for anti-human papillomavirus type 31 serum
|
First WHO International Standard for anti-human papillomavirus type 31 serum
|
|
SRNC-19/290
|
First WHO International Standard for anti-human papillomavirus type 33 serum
|
First WHO International Standard for anti-human papillomavirus type 33 serum
|
|
SRNC-20/178
|
First WHO International Standard for anti-human papillomavirus type 45 serum
|
First WHO International Standard for anti-human papillomavirus type 45 serum
|
|
SRNC-19/296
|
First WHO International Standard for anti-human papillomavirus type 52 serum
|
First WHO International Standard for anti-human papillomavirus type 52 serum
|
|
SRNC-19/300
|
First WHO International Standard for anti-human papillomavirus type 58 serum
|
First WHO International Standard for anti-human papillomavirus type 58 serum
|
|
SRNC-19/298
|
First WHO International Standard for anti-human papillomavirus type 6 serum
|
First WHO International Standard for anti-human papillomavirus type 6 serum
|
|
SRNC-21/112
|
First WHO International Standard for Lassa virus RNA
|
First WHO International Standard for Lassa virus RNA
|
|
SRNC-20/152
|
First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays
|
First WHO International Standard for Mycobacterium tuberculosis (H37Rv) DNA for NAT-based assays
|
|
SRNC-20/146
|
First WHO International Standard for SARS-CoV-2 RNA
|
First WHO International Standard for SARS-CoV-2 RNA
|
